Pharmacology of polyriboinosinic: polyribocytidylic acid, a new antiviral and antitumor agent.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000494:pharmacology*; D003596:Cytosine; D004622:Embryo, Mammalian / Q000187:drug effects; D005260:Female; D000882:Haplorhini; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D011070:Poly I-C; D011119:Polynucleotides / Q000138:chemical synthesis / Q000627:therapeutic use* / Q000633:toxicity; D011247:Pregnancy; D012313:RNA / Q000138:chemical synthesis / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D011817:Rabbits; D051381:Rats
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D011119:Polynucleotides; D012313:RNA; D003596:Cytosine; D011070:Poly I-C